Novartis inks $1B-plus biobucks deal with Flagship`s Generate
25 Sep 2024 //
BIOSPACE
Firefly Advances AI-Driven BNA™ Technology in Neuroscience
20 Sep 2024 //
GLOBENEWSWIRE
Novartis Gets Broad FDA Approval For Kisqali In Early Breast Cancer
18 Sep 2024 //
PR NEWSWIRE
PanTera Attracts $102.5M In Series A For Radiopharmaceutical Manufacturing
12 Sep 2024 //
ENDPTS
Relay Therapeutics` Combo Cuts Breast Cancer Progression In Early Study
10 Sep 2024 //
REUTERS
Despite trial scare, Travere`s IgAN drug wins full FDA approval
06 Sep 2024 //
FIERCE PHARMA
Novartis ignites new stage of Voyager pact with $15M capsid deal
05 Sep 2024 //
FIERCE BIOTECH
Novartis Begins Construction of New Radioligand Therapy Facilities in the US
05 Sep 2024 //
PR NEWSWIRE
Novartis brings blood cancer sculptures to Scotland, symptom awareness
02 Sep 2024 //
FIERCE PHARMA
Novartis` Leqvio Shows Promise in Lowering Cholesterol
29 Aug 2024 //
CONTRACT PHARMA
With phase 3 win, Novartis pads case for broader use of heart med Leqvio
28 Aug 2024 //
FIERCE PHARMA
Novartis To Spend $1B On New Biologics Formulations
28 Aug 2024 //
FIERCE PHARMA
Novartis Twice-Yearly Leqvio Demonstrated Clinically Meaningful LDL-C Lowering
28 Aug 2024 //
GLOBENEWSWIRE
Versant’s Jerel Davis on build-to-buy deals and pharma investment
26 Aug 2024 //
BIOPHARMADIVE
Siemens Healthineers To Acquire Novartis` European Radiodiagnostic Network
26 Aug 2024 //
FIERCE BIOTECH
Novartis Receives Offer From Siemens Healthineers For Molecular Imaging Unit
24 Aug 2024 //
REUTERS
Novartis and Versant Partner to Form Kidney Disease Biotech
23 Aug 2024 //
BIOSPACE
Novartis loses initial bid to block generic of best-selling heart drug
13 Aug 2024 //
REUTERS
Immunic Reports Q2 2024 Results And Provides Corporate Update
08 Aug 2024 //
PR NEWSWIRE
US FDA Approves Novartis` Kidney Disease Drug
08 Aug 2024 //
REUTERS
Novartis, Viatris face new lawsuit over `HeLa` cell misuse claims
06 Aug 2024 //
REUTERS
Novartis Files FDA Complaint In Entresto Patent Defense
01 Aug 2024 //
FIERCE PHARMA
Biogen lifts profit forecast, signals progress in turnaround effort
01 Aug 2024 //
REUTERS
US court finds ‘robust’ anti-fraud safeguards in Novartis settlement
29 Jul 2024 //
REUTERS
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
25 Jul 2024 //
FIERCE BIOTECH
Dren Bio And Novartis Partner On Cancer Myeloid Engagers
24 Jul 2024 //
BUSINESSWIRE
Novartis taps Dren Bio in $3B pact focused on myeloid engagers
24 Jul 2024 //
ENDPTS
Drug giants eye China for deals despite growing Sino-US tensions
23 Jul 2024 //
REUTERS
‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO
19 Jul 2024 //
FIERCE BIOTECH
Novartis CEO: IRA Impact Manageable, Maintains Midterm Growth Goal
19 Jul 2024 //
FIERCE PHARMA
Novartis Reports Strong Q2 Growth And Raises 2024 Guidance
18 Jul 2024 //
GLOBENEWSWIRE
Novartis raises 2024 profit guidance for second time
18 Jul 2024 //
REUTERS
US FDA to ban use of brominated vegetable oil in food, soda
03 Jul 2024 //
REUTERS
As former BMS CEO Giovanni Caforio plots move to Novartis
01 Jul 2024 //
FIERCE PHARMA
Pfizer poaches Novartis exec for oncology commercial chief post
29 Jun 2024 //
FIERCE PHARMA
Novartis Pharms Corp Biologic Crizanlizumab-Tmca Receives Approval in US
26 Jun 2024 //
FDA
GSK, Moderna, Novartis and more join Slope in new biospecimen consortium
25 Jun 2024 //
FIERCE BIOTECH
MorphoSys And Novartis Plan Merger Squeeze-Out Of Minority Shareholders
20 Jun 2024 //
BUSINESSWIRE
Aerovate`s stock plummets after sole product fails in PAH trial
18 Jun 2024 //
FIERCE PHARMA
Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month
12 Jun 2024 //
FIERCE PHARMA
Italy starts probe into Lucentis biosimilar delay allegation
08 Jun 2024 //
PHARMAPHORUM
Novartis, Roche unit and others face Italy antitrust probe over eye drug
07 Jun 2024 //
REUTERS
Dr. Selvaggi, Oncology Expert, Joins CEL-SCI As Clinical Advisor
06 Jun 2024 //
BUSINESSWIRE
Cytokinetics confirms acquisition talks with Novartis were halted
05 Jun 2024 //
INVESTING
Novartis Scemblix ph III data first to show superior efficacy tolerability
03 Jun 2024 //
PHARMABIZ
Novartis Sues Maryland Over 340B Discount Restrictions
31 May 2024 //
ENDPTS
Novartis Scemblix Shows Superior Efficacy, Safety In Newly Diagnosed CML
31 May 2024 //
GLOBENEWSWIRE
Novartis Remibrutinib Data Confirm Efficacy And Safety In Urticaria
30 May 2024 //
GLOBENEWSWIRE
Novartis ends development of KRAS drug, citing `increasing options available
30 May 2024 //
ENDPTS
Novartis’ ASCO booth uses AR to simulate patient burden
29 May 2024 //
FIERCE PHARMA
A personal journey full circle Earth to transformative therapies at Novartis
27 May 2024 //
PRESS RELEASE
Novartis` atrasentan shows to reduce proteinuria in Phase III IgAN trial
27 May 2024 //
CLINICALTRIALSARENA
Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products
27 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Novartis Presents Latest Phase III Fabhalta Data
25 May 2024 //
PRESS RELEASE
Novartis Fabhalta® C3G Phase 3: 35.1% Proteinuria Reduction Vs Placebo
25 May 2024 //
GLOBENEWSWIRE
Novartis Atrasentan IgAN Phase 3: Proteinuria Reduction Portfolio Advancement
25 May 2024 //
GLOBENEWSWIRE
JB Pharma expects India business to grow above market growth rate in FY25
21 May 2024 //
ECONOMICTIMES
Novartis Meets Conditions For $68/Share MorphoSys Acquisition
16 May 2024 //
GLOBENEWSWIRE
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
16 May 2024 //
REUTERS
BeiGene looks at new partnerships,with full cancer pipeline & growing footprint
15 May 2024 //
ENDPTS